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Mutational analysis of designed peptides that undergo structural
transition from α helix to β sheet and amyloid fibril formation
Yuta Takahashi1, Akihiko Ueno1 and Hisakazu Mihara1,2*
Background: Conformational alteration and fibril formation of proteins have a
key role in a variety of amyloid diseases. A simplified model peptide would lead
to a better understanding of underlying mechanisms whereby protein misfolding
and aggregation occur. Recently, we reported the design of peptides that
undergo a self-initiated structural transition from an α helix to a β sheet and form
amyloid fibrils. In this study, we focus on two glutamine residues in the peptide,
and report a mutational analysis of these residues.
Results: A coiled-coil α-helix structure bearing a hydrophobic
adamantanecarbonyl (Ad) group at the N terminus was designed (parent
peptide Ad-QQ). In neutral aqueous solution, the double Gln→Ala mutant
(Ad-AA) underwent the α→β structural transition within four hours, which was
similar to the case of Ad-QQ. In contrast, two kinds of single Gln→Ala mutant
(Ad-QA and Ad-AQ) required three days for the transition. Furthermore, Ad-QQ
and Ad-AA formed amyloid fibrils, whereas Ad-QA and Ad-AQ did not.
Interestingly, however, Ad-QA and Ad-AQ complementarily assembled into the
fibrils when they were mixed.
Conclusions: The Gln→Ala substitution in the peptide significantly alters the
α→β transitional properties and the ability to form amyloid fibrils. A
heterogeneous assembly of two peptide species into the fibrils is also presented.
These results suggest that the secondary structural transition and self-assembly
into the well-organized fibril may depend strictly on the primary structure, which
determines the β-sheet packing. The results might provide insights into
misfolding and fibril formation of disease-associated mutant proteins. 
Introduction
Conformational alteration of proteins and peptides has
attracted much attention because it is of relevance to a
number of serious diseases, as recent studies have pointed
out [1–9]. The misfolding of proteins often causes both
ordered and disordered protein aggregation [1]. Amyloid
fibrils are an example of protein aggregates with a regular
quaternary structure that have been proposed as causative
agents of the so-called amyloid diseases (amyloidosis),
such as Alzheimer’s and prion diseases [9–13]. The
pathway of protein misfolding and subsequent fibril for-
mation involves a conformational transition, for example,
from an α-helix to a β-sheet structure. This transition is
most apparent in the conversion of prion proteins from
normal to abnormal isoforms [13]. The cellular form of the
prion protein (PrPC) forms a predominantly α-helical
structure and is highly water-soluble, but the scrapie
isoform (PrPSc) forms amyloid fibrils with a higher β-sheet
content. Similarly, the β-amyloid peptide (Aβ), which is a
major component of the amyloid plaques deposited in the
brains of Alzheimer’s disease patients, has an α-helical
propensity in some environments [10–12]. It is becoming
increasingly important to study the nature of these proteins
in order to understand such diseases. Recent studies have
suggested that relatively unstable folding states (partially
folded/unfolded states), which occur in some environ-
ments or in the presence of an unfavorable mutation, are
important in determining whether proteins misfold and
aggregate [4,8]. In general, one cause of protein misfolding
and aggregation is thought to be the exposure of the
hydrophobic region of such unstably folded proteins to an
aqueous environment.
Peptides based on the de novo design have provided useful
information for constructing and manipulating peptide
conformations and elucidating complex folding mecha-
nisms [14,15]. The design method often utilizes the
amphiphilic nature of peptide secondary structures to con-
struct tertiary structures of artificial proteins [16]. Peptides
designed for β-sheet folding have been extensively
studied [17,18], and the design of peptides that adopt fib-
rillar structures is of interest [19–23]. Moreover, designing
sequences of peptides to allow conformational intercon-
versions (e.g. helix/sheet switching) has been widely
attempted utilizing techniques such as de novo sequence
design [23–29] and sequence manipulation of natural
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proteins [30–32]. For example, some peptides form either
an α helix or a β sheet depending on the solution environ-
ments [23–29]. Furthermore, a structural transition from
α helix to β sheet is also suggested in a correct folding
pathway with a non-hierarchical mechanism [33]: it has
been proposed that a predominantly β-sheet protein,
β-lactoglobulin, folds through a non-native α-helix-rich
intermediate [33]. These studies suggest that both overall
and local conformations of proteins and their conversion
are determined not only by local amino acid sequences
(short-range interactions between nearby amino acid
residues) but also by mainly long-range (both intra- and
intermolecular) interactions between secondary structures.
Recently, we have reported the design of peptides that
undergo self-initiated structural transitions from an α helix
to a β sheet and amyloid fibril formation, caused by the
exposure of a hydrophobic domain attached to the N ter-
minus [34–36]. The first success of this approach for
designing α→β transitional peptides was accomplished
using a 1-adamantanecarbonyl (Ad) group as the exposed
hydrophobic domain at the N terminus of the two-helix
peptide [34]. In aqueous solution, the Ad-linked two-helix
peptide underwent the α→β transition and amyloid fibril
formation in an autocatalytic manner. To explore the effect
of the hydrophobic domain, we further investigated pep-
tides with a variety of aliphatic acyl chains at the N termini
[35]. It became clear that acyl chains of particular length
caused the peptides to undergo the α→β transition, and
that there was an optimum length (hydrophobicity), such
as the octanoyl (C8) group, for the transition [35]. More-
over, we have confirmed that these non-amino acid moi-
eties at the N termini are replaceable by standard
hydrophobic amino acids, such as leucine, phenylalanine or
tryptophan, retaining the transitional and fibril-forming
abilities [36]. The peptide sequence that we previously
designed was expected to form both amphiphilic α helices
and β strands [34–36], and when the peptide could adopt a
β strand, two hydrophilic glutamine residues, which have
hydrogen-bonding abilities, were expected to constitute a
β-strand face along with hydrophobic leucine residues.
Here, we describe the investigation of a series of Gln→Ala
mutant peptides used to examine the contributions of the
glutamine residues to the conformational properties. The
substitution significantly affects the α→β transition and
amyloid fibril formation. Additionally, the importance of
structural complementarity in the formation of amyloid
fibrils is discussed. 
Results
Design of Gln→Ala mutant peptides
Peptides undergoing α→β structural transitions and
amyloid fibrillogenesis were designed as previously
described [34–36]. The peptides were composed of two
amphiphilic α helices, and Ad groups [34] or acyl chains of
various lengths [35] were attached to the N termini as an
exposed hydrophobic domain. The two-helix peptide was
constructed from amino acid sequences of coiled-coil pro-
teins [37]. The amphiphilic α helix had double heptad
repeats of (ALEQKLA)2 (the parent peptide QQ;
Figure 1a). When the peptide sequence was drawn as a
β-strand model, however, the peptide could adopt an
amphiphilic β-strand structure, in which hydrophobic
leucine residues and charged glutamate and lysine residues
were separated on different faces of each heptad
(Figure 1b). In this model, hydrophilic glutamine residues
at positions 5 and 12 of the QQ peptide, which have a
hydrogen-bonding ability, are expected to constitute a
β-strand face along with hydrophobic leucine residues. In
order to examine the contributions of the two glutamine
residues in the α→β structural transition and amyloid fib-
rillogenesis, mutant peptides with single or double
Gln→Ala substitutions (QA, AQ and AA peptides) were
designed (Figure 1). As an exposed hydrophobic domain,
which would facilitate intermolecular peptide associations,
the Ad group was attached to the N termini [34]. Peptides
that lacked the hydrophobic domain (i.e. acetylated, Ac,
peptides) were also prepared. All peptides were synthe-
sized using solid-phase methods with 9-fluorenylmethyl-
oxycarbonyl (Fmoc) chemistry [38]. The two polypeptide
chains were linked by the disulfide bond between cysteine
residues at the C termini to maintain a parallel orientation. 
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Figure 1
Structure of the peptides. (a) The primary
structure of the Gln→Ala mutant peptides
with or without the adamantanecarbonyl
group at the N termini. (b) A helix wheel
drawing as a coiled-coil form, and a β-strand
drawing of the core 14-amino-acid peptide. 
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Structure
Structural transition of the peptides from α helix to β sheet
The conformational changes of the peptides with Gln→Ala
substitutions were examined by circular dichroism (CD)
spectroscopy (Figure 2). All peptides showed CD spectra
typical for an α-helical structure shortly after dilution in
20 mM Tris-HCl buffer (pH 7.4) from the trifluoroethanol
(TFE) solution (final peptide concentration 10 µM; TFE
content 2.5%). The CD measurements of the four Ad-
linked peptides revealed a gradual change in the spectrum
typical for a β-sheet structure, but the rates of conforma-
tional changes were significantly different depending on
their sequences (Figure 2a). The α→β transition of the
parent peptide, Ad-QQ, and the double Gln→Ala mutant,
Ad-AA, occurred at the highest transitional rate, and their
transitions were completed within 4 h at 25°C. When the
lyophilized powder of the peptide was directly dissolved in
the buffer (i.e. without TFE) the peptide underwent the
α→β transition similarly to when TFE was used as the
stock solvent. In addition, when the fully denatured
peptide in 6 M guanidine hydrochloride (GuHCl) was
diluted with buffer without TFE to a final concentration of
0.1 M GuHCl, the peptide formed the α-helix structure at
first, and transformed to the β sheet spontaneously. Thus,
the initial α-helix structure is not brought about by TFE.
For quantitative sample preparations, TFE stock solutions
were used. The time courses of the structural transitions of
Ad-QQ and Ad-AA, monitored by the ellipticity at 205 nm,
were sigmoidal indicating that the transitions occurred in
an autocatalytic manner, as suggested for Αβ peptides and
prion proteins [9]. The transition curves of these peptides,
however, showed little difference in their shapes. Ad-QQ
had ~90 min of lag time (no transitional phase), whereas
Ad-AA showed a slow transitional phase before the follow-
ing rapid transitional phase. In contrast to the transition of
Ad-QQ and Ad-AA, which was completed within 4 h, the
transition rates of the single Gln→Ala mutant peptides,
Ad-QA and Ad-AQ, were significantly retarded taking
3 days to complete the transition. 
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Figure 2
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Circular dichroism (CD) studies of the peptides. Time-dependent CD spectral changes of (a) Ad-linked peptides and (b) acetylated peptides. Insets
show time courses of the α→β structural transitions of the peptides monitored by the molar ellipticity at 205 nm. [Peptide] = 10 µM in 20 mM Tris HCl
buffer (pH 7.4)/2.5% TFE at 25°C.
The conformational properties of the acetylated peptides
were also examined (Figure 2b). The acetylated peptides
(except for Ac-AA) retained an α-helix conformation and
did not show the structural changes over 3 days, but Ac-
AA completed the α→β transformation within 11 h. In
previous reports [34,35], we concluded that the appropri-
ate hydrophobic nucleation domain, such as the Ad or C8
group, was essential for the α→β transition, because the
acetylated parent peptide (Ac-QQ) did not possess this
transitional ability. However, in the case of the AA
peptide, it is likely that the peptide sequence itself has
the potential to nucleate, which would initiate the α→β
transition, because the hydrophobicity of the peptide
increases due to the double Gln→Ala substitutions (dis-
cussed below). The introduction of the Ad group was effec-
tive in increasing the transitional rate of the AA peptide. 
Fourier-transform infrared (FTIR) measurements con-
firmed that the peptides transformed to a β-sheet struc-
ture. The peptide solutions were prepared and incubated
using the same methods as for the CD measurements.
Following the appropriate incubation periods for the tran-
sitions (4 h for Ad-QQ and Ad-AA, 3 days for Ad-QA and
Ad-AQ, 11 h for Ac-AA), these peptides showed absorp-
tion spectra that suggested a β-sheet structure (amide I
peak maxima at 1620–1630 cm–1) [39].
α-Helix structure before the structural transition
In the previous studies [34,35], we demonstrated that the
association state and stability of the α-helix structure in
the initial stage are significant determinants for the transi-
tional property of the peptides. Thus, a size-exclusion
chromatographic analysis was carried out for the initial
α-helix conformation. The peptides in TFE were injected
onto a Superdex 75 HR column equilibrated with buffer;
thus the retention time of the peptides could reflect their
molecular association in the initial stages. The gel-filtra-
tion analysis revealed that all peptides were predomi-
nantly monomeric initially (Figure 3). However, the
elution profiles of the peptides were slightly different
depending on the sequences. The elution peak of Ad-QQ
and Ac-QQ was symmetric, suggesting the absence of
strong intermolecular associations in the initial stages. By
contrast, the other mutant QA, AQ and AA peptides (both
Ad and Ac) showed an asymmetric elution peak with a
shoulder in earlier retention time. This result indicated
that intermolecular associations occurred for the mutant
peptides, even in the initial stages, although they were
predominantly monomeric. This is because of the
increased hydrophobicity of the hydrophilic sides of the
amphiphilic α helices owing to the Gln→Ala substitution. 
Denaturation studies using GuHCl were also carried out
for the initial α-helix structure (Table 1). Increased
numbers of alanine residues stabilized slightly the α-helix
structure, owing to a higher α-helical propensity of alanine
[14]. In addition, some stability might be conferred from
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Figure 3
Gel-filtration analysis of the peptides. Each peptide was dissolved in TFE
and analysed using a Superdex 75HR 10/30 column. Eluant, 50 mM
phosphate buffer (pH 7.0); flow rate, 0.5 ml min–1; detection, 220 nm. 
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Table 1
Stability of the initial α-helix structure of peptides estimated
from guanidine hydrochloride denaturation.
Peptide –∆GH2O/kcal mol
–1 Transition*
Ad-QQ 0.97 ± 0.10 4 h
Ad-QA 1.11 ± 0.08 3 days
Ad-AQ 1.08 ± 0.04 3 days
Ad-AA 1.41 ± 0.09 4 h
Ac-QQ 0.45 ± 0.03 None
Ac-QA 0.69 ± 0.08 None
Ac-AQ 0.65 ± 0.08 None
Ac-AA 0.87 ± 0.03 11 h
*The conformation of the peptides changed from α helix to β sheet
within the indicated periods.
partial intermolecular association as suggested by the gel-
filtration analysis. The significantly slow transition rates of
Ad-QA and Ad-AQ are not derived from the slightly
increased stabilities of the initial α helix as Ad-AA has a
higher stability of the initial α-helix but shows a higher
transition rate. It should be noted that the stabilities of the
initial α-helix structure of the peptides that underwent
the α→β transition were in the range of the stabilities of
our previously reported peptides that underwent the tran-
sition (∆GH2O –0.8 to –1.8 kcal mol
–1) [35].
The importance of the initial α-helix structure was also
confirmed by the following result. All single-stranded pep-
tides with identical sequences, in which the cysteine
residue at the C terminus was protected with an
acetamidomethyl (Acm) group, were almost in a random
coil and did not undergo transformation. Therefore, the
transitional property is determined not only by the peptide
sequence but also by the initial secondary structure.
Amyloid fibril formation
CD and FTIR studies revealed that there was little differ-
ence in the secondary structure of the peptides, either in
the α helix or the β sheet. However, the aggregated states
of the peptides following the transition were quite differ-
ent depending on the sequence. Transmission electron
microscopic measurements showed that Ad-QQ, Ad-AA
and Ac-AA in the β-sheet structure, which were prepared
and incubated as described in the CD study, formed a fib-
rillar structure (Figure 4a). The fibrils had a morphology
similar to that of naturally occurring amyloidogenic pro-
teins, such as Aβ or prion proteins [40,41]. On the contrary,
in the cases of Ad-QA and Ad-AQ in the β-sheet form,
which showed significantly slow transitional rates, no fibril-
lar aggregates were observed. Representative aggregates
formed by Ad-AQ in the β sheet are shown in Figure 4b. 
The amyloid formation was also examined using an
amyloid-specific dye-binding analysis (Figure 5). It is known
that a fluorescent dye, thioflavin T (ThT), associates with
amyloid fibrils and the binding gives rise to a significant
enhancement in fluorescence according to the amount of
fibrils [42,43]. All α-helical peptides (shortly after dilution
in the buffer from TFE) did not affect ThT fluorescence.
In the presence of Ad-QQ, Ad-AA or Ac-AA (10 µM),
which accomplished the transition to β sheet, ThT (6 µM)
showed a new excitation maximum at ~435 nm and a
greatly enhanced fluorescence emission at ~480 nm, a char-
acteristic spectrum for ThT bound to amyloid fibril
(Figure 5a). The amyloid fibrils stained with ThT further
assembled into larger deposits (5–50 µm in size) that could
be observed with fluorescence microscopy [34]. On the
contrary, in the presence of Ad-QA or Ad-AQ (10 µM) after
the transition to the β sheet (3 days after dilution), the dye
showed little enhancement in the fluorescence, suggesting
the absence of amyloid fibrils (Figure 5b), as observed by
electron microscopy. The QQ and AA peptides were able
to assemble into a regular quaternary structure of amyloid
fibrils but QA and AQ were not. 
Heterogeneous assembly into the amyloid fibril
As described above, Ad-QA and Ad-AQ showed slow α→β
transition rates and did not have the ability to form fibrils.
When Ad-QA and Ad-AQ were mixed in a 1:1 ratio (5 µM
each) in the buffer, however, the α→β transition was
significantly accelerated and completed within 9 h
(Figure 6a), whereas each individual peptide required
3 days for the transition (Figure 2a). The transition curve
detected by the ellipticity at 205 nm had two phases (the
first case observed in our studies [34–36]), although the
reason for such a curve was unclear. Furthermore, the
electron microscopic and the ThT-binding studies
showed that the mixture of Ad-QA and Ad-AQ formed
amyloid fibrils after the transition to the β sheet
(Figure 7), whereas neither Ad-QA nor Ad-AQ had the
ability to assemble into fibrils (Figures 4b,5b). It was esti-
mated by the fluorescence intensity of ThT that the
amount of fibrils formed by the 1:1 mixture of Ad-QA and
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Figure 4
Electron micrograph of the peptides after the
structural transition to the β-sheet form.
(a) Ac-AA in β-sheet form. Magnification
50,000 ×; scale bar 200 nm. Similar images
were obtained from Ad-QQ and Ad-AA in
β-sheet form. (b) Ad-AQ in β-sheet form.
Magnification 25,000 ×; scale bar 400 nm.
Similar images were obtained from Ad-QA in
β-sheet form. The peptides were incubated
until they accomplished the transition to
β sheet (4 h for Ad-QQ and Ad-AA, 10 h for
Ac-AA, 3 days for Ad-QA and Ad-AQ), and
then negatively stained. 
Ad-AQ was similar to that formed by Ad-QQ, Ad-AA or
Ac-AA (Figures 5,7b). 
Ad-QA and Ad-AQ were also mixed at different molar
ratios of 3:1 or 1:3 (7.5 µM and 2.5 µM each). CD spec-
troscopy showed that the α→β transition time at these
ratios was slow (2 days) compared with that of the 1:1
mixture (Figure 6b). The ThT-binding analysis revealed
that the amount of fibrils formed by the 3:1 or 1:3 mixture
after the transition was less than that formed by the 1:1
mixture (Figure 7b). It has been shown that equimolar
mixing is optimal in accelerating the transition rate and
assembling the peptides into the fibrils. It is thought that
the QA and AQ sequences are complementary for the
heterogeneous assembly into amyloid fibrils, that is, one is
only able to form the fibrils when the other is present
(Figure 8). By contrast, the QQ and AA peptides are able
to form the fibrils alone; thus, their sequences are self-
complementary and enable the homogeneous assembly. 
Discussion
We have previously demonstrated that attaching an Ad
group to the N terminus of a two-helix peptide as an
exposed hydrophobic domain triggers an α→β structural
transition and amyloid fibril formation in an autocatalytic
manner [34]. To explore the effect of the hydrophobic
domain, we synthesized peptides with a variety of
aliphatic acyl chains at the N termini and examined the
conformational properties [35]. It became clear that acyl
chains of particular length caused the peptides to
undergo an α→β transition and amyloid formation and
that there was an optimum length (hydrophobicity), such
as the C8 group, for the transition. In the present study,
we focused on amino acid residues constituting the core
peptide portion, in particular the two glutamine residues
(Figure 1). It has been shown that the Gln→Ala substitu-
tion in the peptide affects significantly the transitional
properties and aggregate formation. The parent peptide
Ad-QQ and the double-mutant Ad-AA showed higher
transitional rates, whereas the single-mutant peptides
Ad-QA and Ad-AQ had much slower rates (Figure 2a).
Moreover, Ad-QQ and Ad-AA had the ability to self-
assemble into amyloid fibrils, but Ad-QA and Ad-AQ did
not (Figures 4,5), although there was little difference in
the secondary structure of the amyloidogenic and the
non-amyloidogenic peptides (Figure 2). It was interest-
ing that the two peptides having no ability to form the
fibrils, Ad-QA and Ad-AQ, acquired the ability if one was
mixed with the other (Figure 7). It is thought that the
QA and AQ sequences are complementary for the
heterogeneous assembly into amyloid fibrils. These
results suggest that a specific interaction between the
hydrophobic faces of the β strands (β-sheet packing) may
be crucial for a well-organized assembly into the amyloid
fibril. The repeated sequences QQ and AA appeared to
prefer such an assembly, whereas the non-repeated
sequences QA and AQ did not, but were able to assem-
ble complementarily. In other words, the QQ and AA
peptides are able to assemble themselves into the fibrils
by self-recognition of their self-complementary sequences,
whereas the QA and AQ sequences are not self-comple-
mentary and therefore require the complementary
partner for the assembly. It could be assumed that the
assembly of β strands in the QQ peptide is supported by
hydrogen-bonds between the glutamine sidechains,
whereas in the case of the AA peptide it is mainly by
hydrophobic packing, and in the case of the QA/AQ
mixture, by the combination of those interactions.
Figure 8 illustrates the homogeneous assembly of the
920 Structure 2000, Vol 8 No 9
Figure 5
Thioflavin T (ThT) binding analysis of the peptides. (a) Fluorescence
spectra of ThT in the presence of Ad-AA in α helix (thin line) or in β
sheet (bold line). (b) Fluorescence intensity of ThT at 480 nm in the
presence of the peptides in the α-helix or β-sheet forms. The peptides
were incubated until they accomplished the transition to β sheet (4 h
for Ad-QQ and Ad-AA, 11 h for Ac-AA, 3 days for Ad-QA and Ad-AQ),
and then ThT was added. [Peptide] = 10 µM and [ThT] = 6 µM in
20 mM Tris HCl buffer (pH 7.4)/2.5% TFE at 25°C. λex = 435 nm. 
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QQ or AA peptide on the basis of their self-complemen-
tarity, and heterogeneous assembly of the QA and AQ
peptides on the basis of complementary pairing. Consid-
ering the periodicity of the negative and positive charges
in the β strand, in conjunction with the above assumption
of the interfacial interactions, antiparallel alignments of
the molecules in the assembly could be expected as
shown in Figure 8. Although it has been suggested that
polypeptide chains in the amyloid fibrils adopt a cross-β-
structure in which the β strands are aligned perpendicu-
larly to the fiber axis, the precise molecular details of the
structure are not yet fully resolved [44–48]. Both antipar-
allel β sheets [44] and parallel β sheets [45] have been
proposed by means of solid-state nuclear magnetic reso-
nance spectroscopy. 
It has been shown that a similar primary structure (single
mutation) and a similar secondary structure (β sheet) do
not necessarily mean that the peptides are able to form a
similar quaternary structure of amyloid fibrils. It is there-
fore probable that the nature of self-assembly into amyloid
fibrils may strictly depend on the primary structure of the
peptide. In contrast to our results, however, recent reports
have suggested that most proteins might have an inherent
ability to form amyloid fibrils [49,50]. Dobson and cowork-
ers have succeeded in converting proteins that are not
associated with any amyloid disease into amyloid fibrils.
This was accomplished by changing the solution condi-
tions by altering the pH or addition of TFE to promote a
partially unfolded state as an amyloidogenic intermediate
[49,50]. The authors argue that amyloid formation is not
limited to the disease-associated proteins but is an intrin-
sic and common property of many proteins under appro-
priate conditions. Taking this into consideration, conditions
to promote amyloid fibril formation of our non-fibrillo-
genic peptides might be found.
Research Article  α→β Transition and fibril formation of peptides Takahashi, Ueno and Mihara    921
Figure 6
CD study of the mixture of Ad-QA and Ad-AQ.
(a) Time-dependent CD spectral change of
the 1:1 Ad-QA/Ad-AQ mixture. Inset shows
the time course of the molar ellipticity at
205 nm. (b) Time courses of the molar
ellipticity at 205 nm of the mixture at various
ratios. Ad-QA:Ad-AQ = 1:1 (l), 3:1 (u), 1:3
(s), and Ad-QA alone (u) or Ad-AQ alone
(s). [Total peptide] = 10 µM in 20 mM Tris-
HCl buffer (pH 7.4)/2.5% TFE at 25°C. 
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Figure 7
Amyloid fibril formation for the mixture of
Ad-QA and Ad-AQ. (a) Electron micrograph
of the 1:1 Ad-QA/Ad-AQ mixture in β-sheet
form, which was incubated for 9 h and then
negatively stained. Magnification 50,000 ×;
scale bar 200 nm. (b) ThT-binding analysis of
the Ad-QA/Ad-AQ mixture at various ratios.
The mixed peptides were incubated until they
accomplished the transition to the β sheet and
then ThT was added. Ad-QA:Ad-AQ = 1:1,
3:1 or 1:3. Traces are also shown for Ad-QA
alone and Ad-AQ alone. [Total
peptide] = 10 µM and [ThT] = 6 µM in 20 mM
Tris HCl buffer (pH 7.4)/2.5% TFE at 25°C.
λex = 435 nm. 
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In the course of our investigation of the α→β transitional
peptides, we have proposed the transitional mechanism
as follows [34,35]. In the initial stage, the peptide with a
moderate hydrophobic domain, such as the Ad or C8
group, exists in an equilibrium between a monomeric
and oligomeric α-helix structure, although the
monomeric species is dominant. A nucleation of the
α helices occurs during the lag time, and the resultant
long-range (intermolecular) interactions, which stabilize
a β-sheet structure, initiate a cooperative exchange of
hydrogen bonds toward the β-sheet conformation. Once
the β-sheet aggregates appear, monomeric or oligomeric
α helix species could further transform to the β sheet on
the template aggregates, resulting in simultaneous fibril
formation. Whether fibril formation follows or not is
determined critically by the amino acid sequence as
described above, that is, whether the β strands can be
packed well or not. The acetylated parent peptide Ac-
QQ cannot form an α helix nucleus owing to the lack of a
hydrophobic domain, and thus cannot acquire the long-
range interaction that would initiate the α→β transition.
However, Ac-QQ is able to transform to the β sheet if a
small amount of the pre-formed β sheet Ad-QQ is
present [51]. Therefore, the N-terminal hydrophobic
domains are essential for the self-initiation of the α→β
transition. Here, however, we found a mutant peptide
(Ac-AA) undergoing the self-initiated α→β transition but
lacking the hydrophobic domain (Figure 2b). The
double Gln→Ala substitutions increased the hydropho-
bicity of the peptide and thus promoted the intermolecu-
lar association in the α helix, which would initiate the
transition, without the aid of a hydrophobic Ad group.
The elimination of the apparent lag time in the case of
the α→β transition of Ad-AA (Figure 2a), unlike that of
Ad-QQ, may be due also to the increased hydrophobicity
of the peptide portion. 
Here we have focused on glutamine residues, and indeed
it has been shown that these have an important role in the
α→β structural transition and amyloid fibril formation of
the peptides, although it is not clear in detail how they
contribute to the process. It should be noted that gluta-
mine residues contribute significantly to the fibril forma-
tion of several disease-associated amyloidogenic proteins.
For example, hereditary cerebral hemorrhage with amyloi-
dosis (HCHWA) Dutch type is caused by a mutation in
the amyloid precursor protein gene which generates a
Glu22→Gln substitution in Aβ (Aβ-E22Q) [52]. It has
been reported that the substitution accelerates the fibril
formation of the 28-residue Aβ in vitro [53]. Coinciden-
tally, the core portion of our original peptide
(...A2LEQKLAALEQKLA15...) has some sequence homol-
ogy to Aβ-E22Q (...V12HHQKLVFFAQDVG25...; when the
two glutamine residues in both sequences are adjusted,
italicised residues are identical and  those underlined have
a similar value of hydropathy [54]). Similarly, the
Asp178→Asn mutation in the prion protein is associated
with an inherited prion disease [55], and Leu68→Gln in
cystatin C is associated with HCHWA Icelandic type [56].
Moreover, yeast prion proteins have Gln/Asn repeats in
the N-terminal region and a critical role for these is sug-
gested [57,58]. In addition, abnormal expansion of Gln
repeats in proteins that were linked to several inherited
neurodegenerative diseases [59,60] or fibril-forming ability
of a glutamine-rich domain of a DNA-binding protein [61]
have also been reported. These findings suggest that the
assembly of β strands in the QQ peptide or the QA/AQ
mixture is supported by the hydrogen bonds between the
glutamine sidechains. 
In this paper, we present a mutational analysis of designed
peptides that undergo α→β structural transitions and
amyloid fibril formation. The use of simplified model
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Figure 8
Schematic representation of the
complementary assembly of the peptides. The
QQ and AA peptides have self-
complementary sequences that enable them
to assemble into amyloid fibrils. The QA and
AQ sequences are not self-complementary,
therefore, they are not able to assemble into
the fibrils alone, but they are able to assemble
with each other complementarily. 
Structure
AA
QA
AQQQ
+
peptides might divulge a system for clarifying and control-
ling off-pathway aggregation/assembly of naturally occur-
ring proteins. The results demonstrated here might
provide insights into studies on a number of amyloidosis-
related mutant proteins, as well as studies on a structural
basis of well-organized and self-assembling peptides
applicable to nanoscale materials. Further mutational
analysis of the peptide will be reported elsewhere. 
Biological implications
In this paper, we describe a mutational analysis of a
de novo designed peptide that undergoes a self-initiated
structural transition from an α helix to a β sheet and self-
assembly into amyloid fibrils. Such conformational alter-
ation and aggregation/assembly into undesirable forms
exhibited by proteins have been of current interest as
these kinds of phenomena are closely related to a number
of fatal diseases, such as Alzheimer  s and prion diseases.
Detailed studies on the nature of these proteins are there-
fore of importance. The profiles of the structural transi-
tion and the fibril formation of our designed peptides
resemble well those observed in known amyloid proteins. 
In the present study we have focused on two glutamine
residues of the peptide sequence that we designed previ-
ously, and carried out a mutational analysis of these
residues. It has been shown that the Gln→Ala substitu-
tion in the peptide significantly alters the α→β transi-
tional properties and the ability to form amyloid fibrils. It
should be noted that the importance of glutamine
residues in the fibril formation of proteins has been
reported in many cases, including disease-associated pro-
teins. The slight difference in the primary structure of
the peptide alters significantly the structural transition
rate and the aggregate morphology, as reported in point-
mutant amyloidogenic proteins, implying that there may
be a primary structure requirement that enables a
variety of polypeptide chains with low sequential homol-
ogy to assemble into the common fibrillar structure. This
study, using a simplified model system, should be advan-
tageous in elucidating the underlying mechanisms by
which many proteins assemble into fibrils. 
Materials and methods
Peptide synthesis
Peptides were synthesized by the solid phase-method using standard
Fmoc chemistry [38] on an Advanced ChemTech 348 MPS peptide
synthesizer. The peptides were assembled on Rink amide resin that
provided C-terminal peptide amide on cleavage. To introduce the Ad-
groups, 1-adamantanecarboxylic acid was coupled by the same
method for amino acids, and for the Ac peptide acetic anhydride was
used. The peptides were cleaved from resin by trifluoroacetic acid
(TFA) treatment without deprotection of acetamidomethyl (Acm)
groups of cysteine residues. The Acm group was removed by treat-
ment with AgBF4, and the disulfide linkage was formed in 50%
dimethylsulfoxide/1 M HCl [34–36,62,63]. The peptides were puri-
fied by reverse-phase HPLC on C18 or C4 columns (10 × 250 mm)
using a linear gradient of acetonitrile/0.1% TFA. The peptides were
identified by matrix-assisted laser desorption ionization time-of-flight
mass spectrometry on a Shimadzu KOMPACT MALDI III mass
spectrometer and amino acid analysis.
Circular dichroism measurements
CD measurements were performed on a Jasco J-720WI spectro-
polarimeter equipped with a thermoregulator using a quartz cell with
1.0 mm pathlength. Spectra were recorded in terms of mean residue
molar ellipticity ([θ], in deg cm2 dmol–1). Stock solution of each peptide
in TFE was diluted in 20 mM Tris-HCl buffer (pH 7.4). Final concentra-
tions of the peptides were 10 µM and the TFE content was 2.5%. The
concentration of the peptide solutions was determined by quantitative
amino acid analysis. In the previous study [34], the concentration
dependence of the structural transition of Ad-QQ was investigated.
Increases of peptide concentration of up to 10 µM enhanced the tran-
sition rate while shortening the lag time period for β-sheet formation.
However, further increasing the concentration to > 20 µM prevented
the CD measurements due to the formation of insoluble materials. At
concentrations below 10 µM, no visible precipitate was observed;
therefore, 10 µM was selected as the standard concentration. GuHCl
denaturation studies were carried out by preparing the peptide solution
containing GuHCl at various concentrations. The measurements were
performed shortly after the dilution of the TFE stock solution with the
buffer containing GuHCl. The denaturation curves monitored at
222 nm were fitted to the equation ∆Gobs = ∆GH2O –m[GuHCl], where∆Gobs = –RTln((1–f)/f) (f is the fraction of folded peptide), ∆GH2O is the
free energy of folding in the absence of denaturant, and m is the
change in the molar cosolvation free energy [64].
FTIR measurement
Peptide solutions were prepared and incubated as described for the
CD measurements (10 µM peptide in 20 mM Tris-HCl buffer pH 7.4,
with 2.5% TFE at 25°C). The peptide solution was dropped on a CaF2
plate and the solution air-dried. Spectra were recorded on a Perkin
Elmer 1600 spectrophotometer at room temperature. 
Size-exclusion chromatography
For analytical size-exclusion HPLC, a Superdex 75 HR column
(10 × 300 mm; Pharmacia Biotech) was used with 50 mM phosphate
buffer (pH 7.0) as an eluant at a flow rate of 0.5 ml min–1. The following
proteins were used as molecular weight standards: albumin (66,000),
carbonic anhydrase (29,000), cytochrome c (12,400), aprotinin
(6,500), and the insulin B chain (3,500). 
Transmission electron microscopy
Peptide solutions were prepared and incubated as described for the
CD measurements (10 µM peptide in 20 mM Tris-HCl buffer pH 7.4,
with 2.5% TFE at 25°C). The sample was absorbed to a carbon-coated
copper grid (200 mesh) by floating the grid on a drop of the peptide
solution for 30 s. The excess solution was removed by filter paper blot-
ting and the grid was washed by floating on a drop of water for 10 s
and then the water removed. The sample on the grid was negatively
stained with a 2% (w/v) aqueous phosphotungstic acid solution for
30 s and the excess staining solution removed. After drying, the
samples were visualized with a Hitachi H-7500 electron microscope
operating at 100 kV.
ThT fluorescence analysis
A 240 µM solution of ThT (Aldrich Chemical Co) was prepared in
water. A 10 µl aliquot of the ThT stock solution was added to 390 µl of
the peptide solution (final concentrations of ThT and the peptide were
6 µM and 10 µM, respectively), and the fluorescence emission spectra
were recorded immediately at an excitation wavelength of 435 nm at
25°C [42,43]. Fluorescence spectra were measured on a Shimadzu
RF-5300PC spectrofluorophotometer using a 5 × 5 mm quartz cell. 
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